EndoVas
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $16M
Investors
- 5
About EndoVas
Established in 2018 and based in Shanghai, China, EndoVas operates as a medical device developer that mainly provides solutions for peripheral venous disease. The founder of the company, Shengqiang Wang graduated from the East China University of Science and Technology. In April 2024, the company launched the V-Mixtent® venous stent. The company focuses on the research and development and production of vascular interventional medical products. The products that have been launched include the V-Mixtent® venous stent system and the syringe-assisted propulsion pump. The V-Mixtent® venous stent is suitable for three diseases, which are non-thrombotic iliac vein compression syndrome (NIVCS), deep vein thrombosis (DVT), and post-deep vein thrombosis syndrome (PTS). Products under development or in the patent stage include the venous closure system, V-CLOFF® deep vein thrombosis removal system, and vascular filtration protection device. The company generates revenue by providing vascular interventional medical products such as V-Mixtent® venous stent system and the syringe-assisted propulsion pump.
Who invested in EndoVas
5 investors across 1 round
See all investors in EndoVas
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 30, 2021
Amount
$16M
Investors
Questions about EndoVas
Who invested in EndoVas?
EndoVas has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EndoVas raised?
EndoVas has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EndoVas last raise money?
EndoVas's most recent round on record is a Series A, in Dec 2021.
What does EndoVas do?
Established in 2018 and based in Shanghai, China, EndoVas operates as a medical device developer that mainly provides solutions for peripheral venous disease.
Where is EndoVas headquartered?
EndoVas is headquartered in Shanghai, China.
Which VCs invest in companies like EndoVas?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at EndoVas's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like EndoVas? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.